INDEGENE
|
The Current P/E Ratio of INDEGENE is 24.34.
| Share Price | ₹443.8 | Mar 24,2026 |
| Market Cap | ₹10,685.5 Cr | |
| Earnings-TTM | ₹439.0 Cr | TTM-Consolidated Results |
| Price/Earnings | 24.34x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of INDEGENE
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹10,685.5 Cr] as on Mar 24,2026
(/) Earnings [ ₹439.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 24.34x ]
Thus, for INDEGENE , the investors are currently willing to pay 24.34 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of INDEGENE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of INDEGENE over the last five years.
Historical PE (Price/Earnings) ratio chart of INDEGENE
PE Ratio Performance Analysis for INDEGENE
- INDEGENE 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 6.81x.
- INDEGENE 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, INDEGENE 's p/e ratio peaked in Mar2025 at 34.05x.
- INDEGENE 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does INDEGENE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| INDEGENE | 439.00 | 24.34 | 10,685.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 38.23 | 420,555.0 |
| DIVIS LABORATORIES LTD | 2,479.00 | 64.50 | 159,889.0 |
| CIPLA LTD | 4,544.70 | 21.67 | 98,492.9 |
| TORRENT PHARMACEUTICALS LTD | 2,272.00 | 63.41 | 144,073.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 19.08 | 105,133.0 |
| MANKIND PHARMA LTD | 1,796.65 | 45.66 | 82,039.3 |
| ZYDUS LIFESCIENCES LTD | 4,933.90 | 18.08 | 89,202.6 |
| LUPIN LTD | 4,669.18 | 22.83 | 106,603.0 |
| AUROBINDO PHARMA LTD | 3,513.20 | 21.18 | 74,415.2 |
| ABBOTT INDIA LTD | 1,524.13 | 37.40 | 56,998.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs INDEGENE 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.08x |
| Max industry PE | 64.50x |
| Median industry PE | 24.34x |
| Average industry PE | 34.22x |
You may also like the below Video Courses